Partner Headlines - BIIB

  1. Majority Of IBD 50 Firms Strong On Sponsorship

    IBD
  2. Biogen's buy rating reaffirmed

    IBD
  3. UPDATE: Morgan Stanley Reiterates On Biogen Idec Following Plegridy ...

    Benzinga
  4. Perrigo Regains Some Lost Ground On Fiscal Q4 Beat

    IBD
  5. Perrigo Q4 Beats Estimates, But Guidance Misses

    IBD
  6. Tech, Health Care Lead Q2 Earnings Beats

    IBD
  7. #PreMarket Primer: Friday, August 8: U.S. To Begin Airstrikes ...

    Benzinga
  8. Top 4 Stocks In The Biotechnology Industry With The Highest Revenue

    Benzinga
  9. Why Investors Should Closely Watch Celgene

    Benzinga
  10. Biotech Gets A Lift On Popular Drug, Strong Pipeline

    IBD
  11. Ken Fisher's Top Increaes of the Second Quarter

    GuruFocus
  12. Ken Fisher's Top Increases of the Second Quarter

    GuruFocus
  13. Chipotle, Facebook Rally On Upside Earnings Surprise

    IBD
  14. Celgene, Alexion Beat Estimates, But Biotechs Fall

    IBD
  15. Celgene, Alexion Earnings Top Street, But Stocks Fall

    IBD
  16. Biogen, Gilead Profits Soar

    IBD
  17. Biogen, Gilead Crush Earnings Estimates On Hot Drugs

    IBD
  18. S&P 500 Posts New High; Biotechs, Airlines, Builders Up

    IBD
  19. IPO Stock Watch: Biotechs Are Half Of July Calendar

    IBD
  20. Vertex Is Poised For An Earnings Breakout

    Benzinga
  21. Pepsi Beats; Positive Phase 3 Breast Cancer Data Creates Potential ...

    Benzinga
  22. S&P 500 Flirts With High; Breadth Missing On Nasdaq

    IBD
  23. Intuitive Surgical Rises On Upbeat Earnings; Xilinx Shares Slip

    Benzinga
  24. S&P 500 Aims At New High; Biotechs Gap Up In Fast Trade

    IBD
  25. Biogen Trounces Q2 Estimates As Tecfidera Outperforms

    IBD
  26. Apple, Microsoft Lead Nasdaq Higher; Dow Falters

    IBD
  27. Markets Mixed; PepsiCo Q2 Earnings Beat Street View

    Benzinga
  28. Stocks: Mixed Open, Mixed Trade; Delta, Broadcom, Biogen Buck ...

    IBD
  29. Morning Market Movers

    Benzinga
  30. UPDATE: Biogen Idec Posts Stronger-Than-Expected Q2 Results, ...

    Benzinga
  31. Stock Futures Up, But Wobbly; Boeing, Apple, Biogen Rising

    IBD
  32. Benzinga's Top #PreMarket Gainers

    Benzinga
  33. Earnings Scheduled For July 23, 2014

    Benzinga
  34. Stocks Rise; Apple, Microsoft Steady In Post-Session

    IBD
  35. Alexion, 3 Other Top Biotechs Reporting Earnings

    IBD
  36. Stocks Climb In Solid Trade; Chipotle Gaps Up, Breaks Out

    IBD
  37. Oil Dominates; Keurig, Constellation Near Buy Points

    IBD
  38. IBD 50 Ends Week Lower But Skyworks Soars

    IBD
  39. Biogen Shares Rebound As Street Has A Change Of Heart

    IBD
  40. Facebook, Gilead Headline IBD 50's Top 5 Earnings

    IBD
  41. IBD 50 Ends Week Lower But Skyworks Soars

    IBD
  42. Biotech Enters Reporting Season With Large Caps Central To Sector ...

    Benzinga
  43. Baxter Q2 Earnings Beat Estimates, But Guidance Soft

    IBD
  44. IBD Big Cap 20 Leaders Hold Up Well Despite Shaky Market

    IBD
  45. Biogen's Profit Rolls Amid Recent Drug Launches

    IBD
  46. Stocks Close Higher As Biotech, Internet Stocks Gain

    IBD
  47. Deutsche Bank Analyst Talks Up Biogen On CNBC; Stock Responds ...

    Benzinga
  48. Alexion Pharma Looks To Life Beyond Its Blockbuster

    IBD
  49. Citi Sees Plenty Of Q2 Earnings Beats Ahead In Biotech Sector

    Benzinga
  50. Biogen Hemophilia Drugs Launch Into The Unknown

    IBD
  51. Top 4 Stocks In The Biotechnology Industry With The Highest EPS

    Benzinga
  52. AbbVie, Shire Give Bullish Guidance Amid Buyout Talk

    IBD
  53. ISIS Pharma Trades Up Premarket; NYT Says Has Potential Heart ...

    Benzinga
  54. Benzinga's M&A Chatter for Monday June 16, 2014

    Benzinga
  55. Biogen, AbbVie Report Positive Top-Line Results from Phase 3 ...

    Benzinga
  56. 50-Day Moving Average Can Buffer A Strong Stock's Advance

    IBD
  57. UPDATE: Morgan Stanley Reiterates On Biogen Idec As Positive ...

    Benzinga
  58. Stock Indexes Slightly Up; Apple Split Takes Effect

    IBD
  59. UPDATE: Morgan Stanley Reiterates On Biogen Idec Following Good ...

    Benzinga
  60. US Stock Futures Slightly Lower Ahead Of McDonald's Sales Report

    Benzinga
  61. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica ...

    Benzinga
  62. Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest ...

    Benzinga
  63. Investor's Corner: How To Use The Big Cap 20

    IBD
  64. Walgreen Shares Climb Sharply in Holiday-Lifted April

    IBD
  65. Walgreen Hits Record Close On Sweet Easter Sales

    IBD
  66. Biogen to Present Plegridy Data from Phase 3 Study at AAN Annual ...

    Benzinga
  67. Market Wrap For April 28: Apple Hits New 52-Week Highs In a Volatile ...

    Benzinga
  68. Amgen Blazed Biotech Trail, Earned 165,233% Reward

    IBD
  69. Market Wrap For April 24: Apple's Smashing Earnings Overshadowed ...

    Benzinga
  70. Biogen EPS misses, guides up

    IBD
  71. Biogen Q1, Guidance Strong, But Stock Slips

    IBD
  72. Market Wrap For April 23: S&P 500 Ends Winning Streak, Apple ...

    Benzinga
  73. Biogen Q1 Sales Beat Street, Guidance Strong

    IBD
  74. Earnings Scheduled For April 23, 2014

    Benzinga
  75. Ken Fisher's Top Increases of the First Quarter

    GuruFocus
  76. A Drill Can Help Identify Right Time To Sell Leaders

    IBD
  77. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
  78. Johnson & Johnson: Why Top Funds Are Buying

    YCharts
  79. Biogen Idec Signs License Agreement With Amunix for XTENylated ...

    Benzinga
  80. Biohazard? Gilead Leads 5 Big-Cap Biotech Earnings

    IBD
  81. Stocks: Thin Gains; Yellen Coaxes Banks To Fortify

    IBD
  82. Biogen to Present Clinical Data from Neurology Portfolio at AAN ...

    Benzinga
  83. IPO Frenzy Freezes As 4 New Issues Delayed

    IBD
  84. Stocks Hit Again; Nasdaq Ends Below 4000

    IBD
  85. Hemophilia drug draws plaudits

    IBD
  86. Market Wrap For April 10: Wednesday's Rally Completely Forgotten

    Benzinga
  87. Biotech IPOs Adamas, Cerulean Slump In Trading Debut

    IBD
  88. Software, Biotech, Solar Names Weigh on Nasdaq

    IBD
  89. Sellers Dictate Action As Growth Stocks Tumble Again

    IBD
  90. Stocks Fall Hard In Early Trade; Biotechs Take Heat Again

    IBD
  91. Stocks Mixed, Volume Mixed; HP, IBM, AT&T Rise

    IBD
  92. Nasdaq Up 1.7%; Bed, Bath & Beyond Sinks After Hours

    IBD
  93. Stocks Extend Gains; Trimble Navigation Finds Support

    IBD
  94. Alexion, Biogen Among Leading Big-Cap Biotechs

    IBD
  95. Don't Panic Over Recent Tech Turmoil

    FoxBusiness
  96. Stocks Rally, Stall, Turn Mixed; Consol Energy, U.S. Steel Jump

    IBD
  97. Biotechs Struggling To Find A Bottom

    Benzinga
  98. Biogen Idec May Have Seeds For Next-Gen MS Drugs

    IBD
  99. Stocks Weaken In Late Trade; Questcor Pares Gains

    IBD
  100. Major Averages Face More Selling, Biotechs Rally Back

    IBD
Trading Center